|
|
|
|
Generic Names of Some Trade Name Drugs, THE MERCK MANUAL OF HEALTH & AGING
Committed to Providing Medical Information Table of Contents Index Enlarge Text Reset Text Shrink Text -- Buy the Book Learn about participating in clinical trials at this government website: www.clinicaltrials.gov - APPENDIX I - Drug Names: Generic and Trade TOPICS - Introduction -~ Some Trade Names of Generic Drugs -~ Generic Names of Some Trade Name Drugs - Generic Names of Some...
|
|
|
Some Trade Names of Generic Drugs, THE MERCK MANUAL OF HEALTH & AGING
Committed to Providing Medical Information Table of Contents Index Enlarge Text Reset Text Shrink Text -- Buy the Book Learn about participating in clinical trials at this government website: www.clinicaltrials.gov - APPENDIX I - Drug Names: Generic and Trade TOPICS - Introduction -~ Some Trade Names of Generic Drugs-~ Generic Names of Some Trade Name Drugs - Some Trade Names of...
|
|
|
Index Z, THE MERCK MANUAL OF HEALTH & AGING
Committed to Providing Medical Information Table of Contents Index Enlarge Text Reset Text Shrink Text -- Buy the Book Learn about participating in clinical trials at this government website: www.clinicaltrials.gov - INDEX - Index-A -~ Index-B -~ Index-C -~ Index-D -~ Index-E -~ Index-F -~ Index-G -~ Index-H -~ Index-I -~ Index-J -~ Index-K -~ Index-L -~ Index-M -~ Index-N -~ Index-O...
|
|
|
Insomnia, Sleep, THE MERCK MANUAL OF HEALTH & AGING
Committed to Providing Medical Information Table of Contents Index Enlarge Text Reset Text Shrink Text -- Buy the Book Learn about participating in clinical trials at this government website: www.clinicaltrials.gov - SECTION 3 Medical Conditions CHAPTER 31 - Sleep TOPICS - Introduction -~ Insomnia-~ Excessive Daytime Sleepiness -~ Limb Movement Disorders -~ Sleep Apnea -~ REM Sleep...
|
|
|
Wyeth: News & Announcements
Back to my archive search Start a new archive search 03/17/1999 American Home Products' Sonata® (Zaleplon), First in a New Generation of Drugs to Treat Insomnia, Receives Marketing Authorization in Europe MADISON, N.J., March 17, 1999 -- American Home Products Corporation (NYSE: AHP - news) and its Wyeth-Ayerst Laboratories Division announced today that the European...
|
|
|
Wyeth: News & Announcements
Back to my archive search Start a new archive search 05/17/1999 American Home Products Corporation Launches Sonata ® in Denmark and Sweden MADISON, N.J., May 17, 1999 -- American Home Products Corporation (NYSE: AHP) and its Wyeth Lederle Division today announced the launch of Sonata ® (zaleplon), a new treatment for insomnia, in Denmark and Sweden.
Food and Drug...
|
|
|
Wyeth: News & Announcements
Back to my archive search Start a new archive search 06/01/1999 AMERICAN HOME PRODUCTS LAUNCHES SONATAA® IN GERMANY Madison, N.J., June 1, 1999 -- American Home Products Corporation (NYSE: AHP) and its Wyeth Lederle Division today announced the launch of SonataA® (zaleplon), a new treatment for insomnia, in Germany.A- Germany is the third European country where Sonata...
|
|
|
Wyeth: News & Announcements
Back to my archive search Start a new archive search 08/16/1999 American Home Products Announces FDA Approval for Sonata(R) (Zaleplon), A Breakthrough Approach to Treat Insomnia First New Product for Insomnia in Over Five Years Offers Flexible Administration MADISON, N.J., Aug.
16, 1999 -- American Home Products Corporation's (NYSE:AHP) pharmaceutical division, Wyeth-Ayerst...
|
|
|
Wyeth: News & Announcements
Back to my archive search Start a new archive search 09/15/1999 AMERICAN HOME PRODUCTS ANNOUNCES SONATA ® (ZALEPLON) CLEARS FINAL REGULATORY HURDLE FOR U.S.
MARKETING Breakthrough Approach For Insomnia Will Be Available Soon Offers Flexible Administration Madison, N.J., September 15, 1999 -- American Home Products Corporation's (NYSE: AHP) pharmaceutical division, Wyeth...
|
|
|
Wyeth: News & Announcements
Back to my archive search Start a new archive search 10/18/1999 American Home Products Corporation Briefs Analysts on Research and Development Progress Madison, N.J., October 18, 1999 -- American Home Products Corporation (NYSE:AHP) held a meeting today for more than 300 securities analysts and investors to discuss AHP's global pharmaceutical business with an emphasis on the Company...
|
|
|
Wyeth: News & Announcements
Back to my archive search Start a new archive search 02/07/2001 SONATA® (zaleplon) C-IV NOW USED BY ASTRONAUTS IN SPACE - Sleep aid available to help shuttle astronauts in outer space overcome the difficulties of falling asleep - St.
But now the space shuttle medicine cabinet offers astronauts the reliability and comfort of the sleep medication Sonata® (zaleplon...
|
|
|
Wyeth: News & Announcements
Back to my archive search Start a new archive search 12/20/2001 AHP And Elan Create Alliance In The Treatment Of Sleep Disorders Elan Will Spearhead U.S.
marketing rights to SonataA® (zaleplon), a novel treatment for sleep disorders that was launched by Wyeth-Ayerst (AHP's pharmaceutical division) in 1999.
This alliance expects to benefit from an expected patent...
|
|
|
Wyeth: News & Announcements
1 Pharmaceutical and Consumer Health Products Company October 22, 1999 CDC Advisory Committee Votes To Recommend First Pneumococcal Conjugate Vaccine for Routine Use in Children October 21, 1999 American Home Products Receives Approval for New Meningitis Vaccine in the United Kingdom October 18, 1999 American Home Products Corporation Briefs Analysts on Research and Development...
|
|
|
Wyeth: News & Announcements
FDA ACCEPTS AMERICAN HOME PRODUCTS CORPORATION'S PMA FOR RECOMBINANT PROTEIN TREATMENT FOR LONG-BONE FRACTURES February 08, 2001 NEW CONTRACEPTIVE HEALTH WEB SITE FOR LEADING 20 MICROGRAM BIRTH CONTROL PILL, ALESSE® February 07, 2001 SONATA® (zaleplon) C-IV NOW USED BY ASTRONAUTS IN SPACE February 05, 2001 EUROPEAN COMMISSION GRANTS MARKETING AUTHORIZATION FOR...
|
|
|
Wyeth: Research & Development: Pipeline
- Wyeth - Research & Development - Product Pipeline About-Wyeth -- Media-Room -- Corporate-Governance -- Wyeth-Divisions -- Products -- Wyeth-Worldwide -- Investor-Relations -- News-&-Announcements -- Research-&-Development -- Educational-Resources -- Careers-at-Wyeth Wyeth: Research & Development: Pipeline Wyeth: Research & Development: Pipeline Wyeth, biotechnology, Celera Genomics...
|
|
|
BioPortfolio Limited
Insomnia - Wake-Up Call for a Sleepy Market TABLE OF CONTENTS EXECUTIVE SUMMARY 5 Introduction 5 Scope and coverage of the Brief 5 Key findings about the topic 6 DIESEASE OVERVIEW 9 Disease definition 9 Epidemiology 11 Economic consequences 15 Summary of patient potential 16 PHARMACOLOGICAL THERAPY 18 Benzodiazepines 18 Drugs used off-label 20 Unmet needs in insomnia 22 BRANDED...
|
|
|
Fonds de Decouvertes Medicales Canadiennes Inc.
Valeur de l'actif net en date du 04/16/04: $9.94 Neurocrine Biosciences Announces Indiplon (NBI-34060) Data Presented at the Associated Professional Sleep Societies (APSS) Meeting (12 juin 2002) Neurocrine Biosciences, Inc
These encouraging results for indiplon further support the potential for safer use in these major insomnia populations
In the case of zaleplon and...
|
|
|
Drugs & Therapy Perspectives Vol. 20, No. 2, 2003
CONTENTS Drugs and Profile Reports Peginterferon- - 2a (40kD) plus ribavirin: a new treatment option takes flight in chronic hepatitis C 1 Dutasteride: profile report* 5 Disease Management Controversy still abounds over the safest and most effective treatment of Graves' disease in children 7 Emollients and keratolytics remain the mainstay of therapy for patients with ichthyosis 11...
author: Adis International Limited
subject: Drugs & Therapy Perspectives
|
|
|
Contents Vol. 43, No. 4, 2004
4, 2004 Contents Leading Article Pharmacokinetic Considerations in Development of a 211- 225 Bioartificial Liver H Iwata, Y Ueda Review Articles Comparative Pharmacokinetics and Pharmacodynamics of 227- 238 Short- Acting Hypnosedatives: Zaleplon, Zolpidem and Zopiclone DR Drover Clinical Pharmacokinetics of Quinupristin/ Dalfopristin 239- 252 DT Bearden Original Research...
author: Adis International Limited
subject: Clinical Pharmacokinetics
|
|
|
Elan: News Article
2/26/2004-08:24 ET Site Map -|- Contact Us -|- Search:- - About Us Products Manufacturing Research & Development News Investor Relations Careers 2004 2003 2002 1/30/2003 6:36:00 AM Elan to Sell Primary Care Franchise to King for $850 Million - DUBLIN, Ireland--(BUSINESS WIRE)--Jan
royalty rights to Sonata Elan Corporation, plc (NYSE: ELN) ("Elan") announced today it has agreed to...
|
|
|
Elan: News Article
2/26/2004-08:23 ET Site Map -|- Contact Us -|- Search:- - About Us Products Manufacturing Research & Development News Investor Relations Careers 2004 2003 2002 2/24/2003 12:47:00 PM Elan Announces Publication of its Shareholder Circular and Sets Date for Special Shareholders Meeting, March 18, 2003 - DUBLIN, Ireland, Feb 24, 2003 (BUSINESS WIRE) -- Elan Corporation, plc (NYSE: ELN) (...
|
|
|
Elan: News Article
2/26/2004-08:23 ET Site Map -|- Contact Us -|- Search:- - About Us Products Manufacturing Research & Development News Investor Relations Careers 2004 2003 2002 3/17/2003 9:22:00 AM Elan Files Suit against King Pharmaceuticals Seeking to Compel the Timely Closing of the Sale of Elan's Primary Care Assets - DUBLIN, Ireland, Mar 17, 2003 (BUSINESS WIRE) -- Elan Corporation, plc (NYSE:...
|
|
|
Elan: News Article
2/26/2004-08:23 ET Site Map -|- Contact Us -|- Search:- - About Us Products Manufacturing Research & Development News Investor Relations Careers 2004 2003 2002 3/18/2003 8:42:00 AM Elan Receives Shareholder Approval for the Sale of Its Primary Care Franchise and for the Disapplication of Pre-Emption Rights - DUBLIN, Ireland--(BUSINESS WIRE)--March 18, 2003--Elan Corporation, plc ...
|
|
|
Elan: News Article
2/26/2004-08:21 ET Site Map -|- Contact Us -|- Search:- - About Us Products Manufacturing Research & Development News Investor Relations Careers 2004 2003 2002 5/8/2003 9:17:00 AM Elan Announces Receipt Of FTC Letter Regarding Skelaxin - DUBLIN, Ireland--(BUSINESS WIRE)--May 8, 2003--Elan Corporation, plc (NYSE: ELN) ("Elan") announced today that it has received a letter from the U.S...
|
|
|
Elan: News Article
2/26/2004-08:21 ET Site Map -|- Contact Us -|- Search:- - About Us Products Manufacturing Research & Development News Investor Relations Careers 2004 2003 2002 5/22/2003 11:16:00 AM Elan Sets Date for Special Shareholders Meeting, June 12, 2003; Announces Publication of Letter to Shareholders Relating To The Amended Terms Of The Sale Of Primary Care Franchise - DUBLIN, Ireland--...
|
